Sun Pharma Slapped With Warning Letter for Dadra Plant’s Multiple Violations

Multiple and repeated violations found in Sun Pharmaceuticals’ Dadra, India facility during a December 2023 FDA inspection have resulted in a Warning Letter following the company’s inadequate responses to a Form 483 levied on it earlier this year.
Source: Drug Industry Daily